Skip to main content
Retour
Watch Compare

ASP Isotopes Inc.

Qualité des données : 100%
ASPI
NASDAQ Manufacturing Chemicals
4,48 €
▲ 0,27 € (6,41%)
Cap. Boursière: 531,72 M
Prix
4,25 €
Cap. Boursière
531,72 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Debt/Equity of 0,19 — conservative balance sheet
Negative free cash flow of -47,13 M
Capital intensive — 147,16% of revenue goes to capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-89,55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-225,09%
En dessous de la moyenne du secteur (-53,58%)
ROIC-22,06%
Net Margin-1057,05%
Op. Margin-431,27%

Sécurité

Debt / Equity
0,19
En dessous de la moyenne du secteur (0,30)
Current Ratio6,14
Interest Coverage-334,83

Valorisation

PE (TTM)
-4,76
En dessous de la moyenne du secteur (-1,48)
P/B Ratio7,18
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -4,8 -1,5
P/B 7,2 1,6
ROE % -225,1 -53,6
Net Margin % -1057,1 -41,5
Rev Growth 5Y % — 1,8
D/E 0,2 0,3

Objectif de Cours des Analystes

2 analystes
Buy
Actuel
4,48 €
+167.9%
Objectif
12,00 €
11,00 €
12,00 €
13,00 €
Prévisions
P/E Prévisionnel -5,50
BPA Prévisionnel -0,82 €
CA Est. 99,75 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,82 €
-1,00 € – -0,63 €
 99,75 M 2
FY2026 -0,72 €
-1,00 € – -0,44 €
 38,90 M 2

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,14 € -0,41 € -200,0%
Q32025 -0,10 € -0,15 € -50,0%
Q22025 -0,11 € -1,03 € -836,4%
Q12025 -0,10 € -0,12 € -20,0%

ETFs Holding This Stock

CDIG logo CDIG City Different Investments Global Equity ETF
3,02% weight
PSCQX PSCQX
0,39% weight
PSCNX PSCNX
0,39% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,03% weight
IRSSX IRSSX
0,02% weight
RSLFX RSLFX
0,02% weight
SCWCX SCWCX
0,02% weight
CSPCX CSPCX
0,02% weight
RSLCX RSLCX
0,02% weight
CSPAX CSPAX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -89,55% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 10,57 M Net Income (TTM) -111,76 M
ROE -225,09% ROA -61,78%
Gross Margin 23,22% Operating Margin -431,27%
Net Margin -1057,05% Free Cash Flow (TTM) -47,13 M
ROIC -22,06% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,19 Current Ratio 6,14
Interest Coverage -334,83 Asset Turnover 0,06
Working Capital 145,72 M Tangible Book Value 67,22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,76 Forward P/E N/A
P/B Ratio 7,18 P/S Ratio 50,29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,86%
Market Cap 531,72 M Enterprise Value 431,75 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,08
FCF / Share -0,38 OCF / Share -0,25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 147,16% FCF Conversion 42,17%
SBC-Adj. FCF -60,30 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2024 FY2022
Revenue 433 026,0 4,14 M —
Net Income -16,29 M -32,42 M -4,95 M
EPS (Diluted) — -0,63 —
Gross Profit 138 970,0 1,60 M —
Operating Income -16,04 M -26,35 M -5,10 M
EBITDA — — —
R&D Expenses 764 581,0 3,14 M 1,27 M
SG&A Expenses — 521 423,0 —
D&A — — —
Interest Expense 118 547,0 17 872,0 3 382,0
Income Tax -6 133,0 111 449,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2023 FY2024 FY2022
Total Assets 27,54 M 94,35 M 12,50 M
Total Liabilities 8,71 M 43,18 M 2,68 M
Shareholders' Equity 16,30 M 47,90 M 9,82 M
Total Debt — — —
Cash & Equivalents — 61,90 M —
Current Assets 10,51 M 65,74 M 3,30 M
Current Liabilities 5,67 M 7,06 M 1,94 M